Definigen

    OverviewSuggest Edit

    Definigen is a company that provides functional disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids. It develops OptiDIFF, a platform technology that focuses on induced pluripotent stem cell (iPSC) generation, CRISPR-Cas9 gene editing, iPSC differentiation, and custom disease model development. The company delivers its services across life science, drug discovery, and regenerative medicine sectors.
    TypePrivate
    Founded2012
    HQBabraham, GB
    Websitedefinigen.com

    Locations

    Definigen is headquartered in
    Babraham, United Kingdom

    Location Map

    Latest Updates

    Employees (est.) (Feb 2020)14

    Definigen Office Locations

    Definigen has an office in Babraham
    Babraham, GB (HQ)
    Babraham Research Campus Moneta Building B280
    Show all (1)

    Definigen Financials and Metrics

    Summary Metrics

    Founding Date

    2012
    Show all financial metrics

    Definigen Online and Social Media Presence

    Embed Graph

    Definigen Frequently Asked Questions

    • When was Definigen founded?

      Definigen was founded in 2012.

    • How many employees does Definigen have?

      Definigen has 14 employees.

    • Who are Definigen competitors?

      Competitors of Definigen include Nuclera, Pencil Biosciences and BlueRock Therapeutics.

    • Where is Definigen headquarters?

      Definigen headquarters is located at Babraham Research Campus Moneta Building B280, Babraham.

    • Where are Definigen offices?

      Definigen has an office in Babraham.

    • How many offices does Definigen have?

      Definigen has 1 office.